1,190
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Detection of pathogenic variants in Alzheimer’s disease related genes in Bulgarian patients by pooled whole-exome sequencing

, , , , , , , , , , , , ORCID Icon, , , , , , & show all
Pages 74-78 | Received 12 Oct 2022, Accepted 02 Dec 2022, Published online: 09 Jan 2023

References

  • Dumurgier J, Sabia S. Epidemiology of Alzheimer’s disease: latest trends. Rev Prat. 2020;70(2):149–151.
  • Teunissen CE, Verberk IMW, Thijssen EH, et al. Blood-based biomarkers for Alzheimer’s disease: towards clinical implementation. Lancet Neurol. 2022;21(1):66–77.
  • Gatz M, Reynolds CA, Fratiglioni L, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63(2):168–174.
  • Bellenguez C, Küçükali F, Jansen IE, CHARGE, et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nat Genet. 2022;54(4):412–436.
  • Liu CC, Liu CC, Kanekiyo T, et al. Apolipoprotein E and alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106–118.
  • Chen F, Swartzlander DB, Ghosh A, et al. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer’s disease neuropathology. Mol Neurodegener. 2021;16(1):5.
  • Tanzi RE, Bertram L. Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell. 2005;120(4):545–555.
  • Lanoiselée HM, Nicolas G, Wallon D, orators of the CNR-MAJ project, et al. APP, PSEN1, and PSEN2 mutations in early-onset alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med. 2017;14(3):e1002270.
  • Wingo TS, Lah JJ, Levey AI, et al. Autosomal recessive causes likely in early-onset Alzheimer disease. Arch Neurol. 2012;69(1):59–64.
  • Cheng R, Tang M, Martinez I, et al. Linkage analysis of multiplex caribbean hispanic families loaded for unexplained early-onset cases identifies novel alzheimer’s disease loci. Alzheimer’s. Alzheimers Dement (Amst). 2018;10:554–562.
  • Ayodele T, Rogaeva E, Kurup JT, et al. Early-Onset Alzheimer’s disease: what is missing in research? Curr Neurol Neurosci Rep. 2021;21(2):4.
  • Carmona S, Zahs K, Wu E, et al. The role of TREM2 in Alzheimer’s disease and other neurodegenerative disorders. Lancet Neurol. 2018;17(8):721–730.
  • Gratuze M, Leyns CEG, Holtzman DM. New insights into the role of TREM2 in Alzheimer’s disease. Mol Neurodegen. 2018;13(1):66.
  • Ali-Rahmani F, Schengrund CL, Connor JR. HFE gene variants, iron, and lipids: a novel connection in Alzheimer’s disease. Front Pharmacol. 2014;5:165.
  • Hollerer I, Bachmann A, Muckenthaler MU. Pathophysiological consequences and benefits of HFE mutations: 20 years of research. Haematologica. 2017;102(5):809–817.
  • Moon HJ, Herring SK, Zhao L. Clusterin: a multifaceted protein in the brain. Neural Regen Res. 2021;16(7):1438–1439.
  • Kucukkilic E, Brookes K, Barber I, ARUK Consortium, et al. Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer’s disease. Hum Genet. 2018;137(4):305–314.
  • Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet. 2009;41(10):1088–1093.
  • Karczewski KJ, Francioli LC, Tiao G, Genome Aggregation Database Consortium, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–443.
  • Chang X, Wang K. wANNOVAR: annotating genetic variants for personal genomes via the web. J Med Genet. 2012;49(7):433–436.
  • Schlötterer C, Tobler R, Kofler R, et al. Sequencing pools of individuals — mining genome-wide polymorphism data without big funding. Nat Rev Genet. 2014;15(11):749–763.
  • Yang H, Wang K. Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat Protoc. 2015;10(10):1556–1566.
  • Landrum MJ, Lee JM, Benson M, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–D1067.
  • Kopanos C, Tsiolkas V, Kouris A, et al. VarSome: the human genomic variant search engine. Bioinformatics. 2019;35(11):1978–1980.
  • Kulminski AM, Shu L, Loika Y, et al. Genetic and regulatory architecture of alzheimer’s disease in the APOE region. Alzheimers Demen (Amst). 2020;12(1):e12008.
  • Wightman DP, Jansen IE, Savage JE, 23andMe Research Team, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for alzheimer’s disease. Nat Genet. 2021;53(9):1276–1282.
  • Hannon E, Shireby GL, Brookes K, et al. Genetic risk for Alzheimer’s disease influences neuropathology via multiple biological pathways. Brain Commun. 2020;2(2):fcaa167.
  • Hagström H, Ndegwa N, Jalmeus M, Swedish Hepatology Study Group (SweHep), et al. Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers. Liver Int. 2021;41(3):545–553.
  • Bolarinwa AB, Onawoga F. Bioinformatics and wet laboratory analysis of r0562 to predict genetic aetiology of iron overload in Nigeria. Am J Clin Pathol. 2021;156(Supplement_1):S145–S146.
  • Vance E, Gonzalez Murcia JD, Miller JB, Alzheimer’s Disease Genetics Consortium (ADGC), et al. Failure to detect synergy between variants in transferrin and hemochromatosis and Alzheimer’s disease in large cohort. Neurobiol Aging. 2020;89:142.e9–e12.
  • Lin Y-S, Cheng C-Y, Liao Y-C, et al. Mutational analysis in familial Alzheimer’s disease of Han Chinese in Taiwan with a predominant mutation PSEN1 p.Met146Ile. Sci Rep. 2020;10(1):19769.
  • Xu Y, Liu X, Shen J, et al. The whole exome sequencing clarifies the genotype- phenotype correlations in patients with early-onset dementia. Aging Dis. 2018;9(4):696–705.
  • Sun L, Zhou R, Yang G, et al. Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of aβ42 and aβ40 peptides by γ-secretase. Proc Natl Acad Sci USA. 2017;114(4):E476–E485.
  • Müller U, Winter P, Bolender C, et al. Previously unrecognized missense mutation E126K of PSEN2 segregates with early onset Alzheimer’s disease in a family. J Alzheimers Dis. 2014;42(1):109–113.
  • Finckh U, Müller-Thomsen T, Mann U, et al. High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. Am J Hum Genet. 2000;66(1):110–117.
  • Zhou SL, Tan CC, Hou XH, et al. TREM2 variants and neurodegenerative diseases: a systematic review and Meta-Analysis. J Alzheimers Dis. 2019;68(3):1171–1184.
  • Arboleda-Bustos CE, Ortega-Rojas J, Mahecha MF, et al. The p.R47H variant of TREM2 gene is associated with late-onset Alzheimer disease in Colombian population. Alzheimer Dis Assoc Disord. 2018;32(4):305–308.
  • Patel D, Mez J, Vardarajan BN, Alzheimer’s Disease Sequencing Project, et al. Association of rare coding mutations with Alzheimer disease and other dementias among adults of European ancestry. JAMA Netw Open. 2019;2(3):e191350.